Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LGND

Ligand Pharmaceuticals Inc

May 14 • 02:23PM ET

216.91

-4.30 -1.94 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: HALO EXEL VKTX ALKS MDGL

| Held by: IJR VTI IWM VB VBR VXF SPSM IJT XSMO IWN

Scroll to Statements

Index	RUT	P/E	29.41	EPS (ttm)	7.38	Insider Own	2.58%	Shs Outstand	20.03M	Perf Week	3.13%
Market Cap	4.35B	Forward P/E	19.43	EPS next Y	11.16	Insider Trans	-7.32%	Shs Float	19.52M	Perf Month	-3.63%
Enterprise Value	4.02B	PEG	1.17	EPS next Q	2.01	Inst Own	104.80%	Short Float	7.45%	Perf Quarter	19.41%
Income	153.56M	P/S	15.84	EPS this Y	11.35%	Inst Trans	1.01%	Short Ratio	6.42	Perf Half Y	3.93%
Sales	274.48M	P/B	4.36	EPS next Y	23.30%	ROA	12.60%	Short Interest	1.46M	Perf YTD	14.73%
Book/sh	49.79	P/C	5.58	EPS next 5Y	16.58%	ROE	17.13%	52W High	247.38 -12.32%	Perf Year	106.41%
Cash/sh	38.89	P/FCF	35.31	EPS past 3/5Y	- -	ROIC	10.60%	52W Low	98.89 119.35%	Perf 3Y	186.73%
Dividend Est.	-	EV/EBITDA	29.61	Sales past 3/5Y	10.96% 7.54%	Gross Margin	83.42%	Volatility	6.36% 4.60%	Perf 5Y	159.54%
Dividend TTM	-	EV/Sales	14.64	EPS Y/Y TTM	210.12%	Oper. Margin	36.88%	ATR (14)	10.31	Perf 10Y	186.35%
Dividend Ex-Date	Jul 02, 2010	Quick Ratio	20.95	Sales Y/Y TTM	51.24%	Profit Margin	55.95%	RSI (14)	46.60	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	21.28	EPS Q/Q	69.66%	SMA20	-4.41%	Beta	1.21	Target Price	270.67
Payout	0.00%	Debt/Eq	0.45	Sales Q/Q	14.09%	SMA50	0.75%	Rel Volume	0.47	Prev Close	221.21
Employees	47	LT Debt/Eq	0.45	Earnings	May 07 BMO	SMA200	13.57%	Avg Volume	226.72K	Price	216.91
IPO	Nov 18, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	-10.23% -11.88%	Trades		Volume	81,611	Change	-1.94%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)